Zobrazeno 1 - 10
of 143
pro vyhledávání: '"beta adrenergic receptor blocking agent"'
Publikováno v:
Revista da Associação Médica Brasileira v.66 n.8 2020
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Vol 66, Iss 8, Pp 1043-1048 (2020)
Revista da Associação Médica Brasileira, Volume: 66, Issue: 8, Pages: 1043-1048, Published: 11 SEP 2020
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Vol 66, Iss 8, Pp 1043-1048 (2020)
Revista da Associação Médica Brasileira, Volume: 66, Issue: 8, Pages: 1043-1048, Published: 11 SEP 2020
SUMMARY OBJECTIVE Monocyte count to HDL-C Ratio (MHR) and Fibrinogen to Albumin Ratio (FAR) have recently emerged as markers of inflammation in atherosclerotic diseases. Our goal was to investigate the relationships of MHR and FAR with the severity o
Publikováno v:
Journal of Arrhythmia
Journal of Arrhythmia, Vol 36, Iss 4, Pp 762-767 (2020)
Journal of Arrhythmia, Vol 36, Iss 4, Pp 762-767 (2020)
Objectives Ivabradine is a pharmacological agent used in patients with heart failure and sinus rhythm. Its only known pharmacological effect is to slow the heart rate. In this study, we investigated the impact of ivabradine on dyssynchrony parameters
Autor:
Nestor Vasquez, Gabriela V. Greenland, M. Roselle Abraham, Sanjay Sivalokanathan, Ketty Dolores-Cerna, Dai Yin Lu, Shibani M. Kudchadkar, Saman Nazarian, Tarek Zghaib, Effrosyni Kontari, Jeffrey E. Olgin, Rob J. van der Geest, Theodore P. Abraham, Ihab R. Kamel, Stefan L. Zimmerman
Publikováno v:
JACC: Clinical Electrophysiology. 5:364-375
OBJECTIVES This study hypothesized that paroxysmal atrial fibrillation (PAF) reflects the presence of a more severe cardiac hypertrophic cardiomyopathy (HCM) phenotype.BACKGROUND HCM is characterized by myocyte hypertrophy, fibrosis, and a high preva
Autor:
Alfredsson, J., James, S. K., Erlinge, D., Herlitz, Johan, Fröbert, O., Dworeck, C., Redfors, B., Arefalk, G., Östlund, O., Jernberg, T., Mars, K., Haaga, U., Lindahl, B., Swahn, E., Lawesson, S. S., Hofmann, R., Investigators, for the DETO2X-SWEDEHEART
Background The purpose of this study is to investigate the impact of oxygen therapy on cardiovascular outcomes in relation to sex in patients with confirmed myocardial infarction (MI). Methods The DETermination of the role of Oxygen in suspected Acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c820232c539b21253d25a2590ff0fc9
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-176830
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-176830
Autor:
Engin, Mesut
Background: The incidence of atherosclerotic cardiovascular diseases, which constitute an important disease group, is expected to rise with increasing life expectancy. The aim of this study was to investigate the predictive values of triglyceride/HDL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9458::b07619ae1e6d97136582ea49fe5abd3c
http://hdl.handle.net/11452/30610
http://hdl.handle.net/11452/30610
Autor:
Rodríguez-Carrio J., Lindholt J.S., Canyelles M., Martínez-López D., Tondo M., Blanco-Colio L.M., Michel J.-B., Escolà-Gil J.C., Suárez A., Martín-Ventura J.L.
Publikováno v:
Journal of Clinical Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
High-density lipoproteins cholesterol (HDLc) levels are decreased in abdominal aortic aneurysm (AAA), which is hallmarked by autoimmunity and lipid aortic deposits. To investigate whether IgG anti-HDL antibodies were present in AAA and their potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::1a421c9757cefbf033a728bb75656aae
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10245
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10245
Autor:
Özge Özden Tok, Asuman Kaftan, Sara Cetin Sanlialp, Yusuf Izzettin Alihanoglu, Mücahit Seçme, Yavuz Dodurga, Ismail Dogu Kilic, Musa Sanlialp, Burcu Uludag, Yasar Enli, Hayrani Eren Bostanci
The accuracy of risk prediction for coronary artery disease can be improved with the use of novel molecular or genetic biomarkers. In this study, we investigated the difference of five selected microRNAs (miR or miRNA) in patients with coronary arter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6ec2c770ac1cc698bf32f7f19e2b2e2
Publikováno v:
Circulation: Arrhythmia and Electrophysiology
Circulation. Arrhythmia and Electrophysiology
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY
Circulation. Arrhythmia and Electrophysiology
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY
Supplemental Digital Content is available in the text.
Background: Long QT syndromes (LQTS) arise from many genetic and nongenetic causes with certain characteristic ECG features preceding polymorphic ventricular tachyarrhythmias (PVTs). However
Background: Long QT syndromes (LQTS) arise from many genetic and nongenetic causes with certain characteristic ECG features preceding polymorphic ventricular tachyarrhythmias (PVTs). However
Autor:
Villanueva C., Albillos A., Genescà J., Garcia-Pagan J.C., Calleja J.L., Aracil C., Bañares R., Morillas R.M., Poca M., Peñas B., Augustin S., Abraldes J.G., Alvarado E., Torres F., Bosch J.
Publikováno v:
LANCET
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Clinical decompensation of cirrhosis is associated with poor prognosis. Clinically significant portal hypertension (CSPH), defined by a hepatic venous pressure gradient (HVPG) =10 mm Hg, is the strongest predictor of decompensation. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::ecf6e96e2a2e86fe5a275bf162110156
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10162
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=10162
Autor:
de Gonzalo-Calvo D., Vilades D., Martínez-Camblor P., Vea À., Ferrero-Gregori A., Nasarre L., Bornachea O., Vega J.S., Leta R., Puig N., Benítez S., Sanchez-Quesada J.L., Carreras F., Llorente-Cortés V.
Publikováno v:
Journal of Clinical Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Epicardial adipose tissue (EAT) constitutes a novel parameter for cardiometabolic risk assessment and a target for therapy. Here, we evaluated for the first time the plasma microRNA (miRNA) profile as a source of biomarkers for epicardial fat volume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c8946df6253f33db10204195e67be539
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075843764&doi=10.3390/jcm8060780&partnerID=40&md5=0bc5b185d2e744281aa89dcc0e2b21fd
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075843764&doi=10.3390/jcm8060780&partnerID=40&md5=0bc5b185d2e744281aa89dcc0e2b21fd